LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | AZD 5438 | 1.11 | uM | LJP6 | 2 | J03 | 72 | hr | 765 | 738 | 3095 | 0.2384 | -0.0177 |
Hs 578T | AZD 5438 | 1.11 | uM | LJP6 | 3 | J03 | 72 | hr | 765 | 724 | 3066 | 0.2361 | -0.0272 |
Hs 578T | AZD 5438 | 3.33 | uM | LJP6 | 1 | J02 | 72 | hr | 765 | 536 | 3143 | 0.1705 | -0.1601 |
Hs 578T | AZD 5438 | 3.33 | uM | LJP6 | 2 | J02 | 72 | hr | 765 | 505 | 3095 | 0.1631 | -0.1862 |
Hs 578T | AZD 5438 | 3.33 | uM | LJP6 | 3 | J02 | 72 | hr | 765 | 527 | 3066 | 0.1719 | -0.1698 |
Hs 578T | AZD 5438 | 10 | uM | LJP6 | 1 | J01 | 72 | hr | 765 | 364 | 3143 | 0.1158 | -0.3053 |
Hs 578T | AZD 5438 | 10 | uM | LJP6 | 2 | J01 | 72 | hr | 765 | 456 | 3095 | 0.1473 | -0.2263 |
Hs 578T | AZD 5438 | 10 | uM | LJP6 | 3 | J01 | 72 | hr | 765 | 384 | 3066 | 0.1252 | -0.2912 |
Hs 578T | Pelitinib | 0.04 | uM | LJP5 | 1 | I18 | 72 | hr | 765 | 3125 | 3140 | 0.9951 | 0.9952 |
Hs 578T | Pelitinib | 0.04 | uM | LJP5 | 2 | I18 | 72 | hr | 765 | 3112 | 3151 | 0.9874 | 0.9876 |
Hs 578T | Pelitinib | 0.04 | uM | LJP5 | 3 | I18 | 72 | hr | 765 | 3157 | 3152 | 1.0015 | 1.0014 |
Hs 578T | Pelitinib | 0.12 | uM | LJP5 | 1 | I17 | 72 | hr | 765 | 3177 | 3140 | 1.0117 | 1.0114 |
Hs 578T | Pelitinib | 0.12 | uM | LJP5 | 2 | I17 | 72 | hr | 765 | 3052 | 3151 | 0.9684 | 0.9688 |
Hs 578T | Pelitinib | 0.12 | uM | LJP5 | 3 | I17 | 72 | hr | 765 | 3105 | 3152 | 0.9850 | 0.9852 |
Hs 578T | Pelitinib | 0.37 | uM | LJP5 | 1 | I16 | 72 | hr | 765 | 2622 | 3140 | 0.8349 | 0.8305 |
Hs 578T | Pelitinib | 0.37 | uM | LJP5 | 2 | I16 | 72 | hr | 765 | 2653 | 3151 | 0.8418 | 0.8383 |
Hs 578T | Pelitinib | 0.37 | uM | LJP5 | 3 | I16 | 72 | hr | 765 | 2575 | 3152 | 0.8168 | 0.8114 |
Hs 578T | Pelitinib | 1.11 | uM | LJP5 | 1 | I15 | 72 | hr | 765 | 2390 | 3140 | 0.7611 | 0.7491 |
Hs 578T | Pelitinib | 1.11 | uM | LJP5 | 2 | I15 | 72 | hr | 765 | 2376 | 3151 | 0.7539 | 0.7417 |
Hs 578T | Pelitinib | 1.11 | uM | LJP5 | 3 | I15 | 72 | hr | 765 | 2422 | 3152 | 0.7683 | 0.7579 |
Hs 578T | Pelitinib | 3.33 | uM | LJP5 | 1 | I14 | 72 | hr | 765 | 1632 | 3140 | 0.5197 | 0.4505 |
Hs 578T | Pelitinib | 3.33 | uM | LJP5 | 2 | I14 | 72 | hr | 765 | 1774 | 3151 | 0.5629 | 0.5095 |
Hs 578T | Pelitinib | 3.33 | uM | LJP5 | 3 | I14 | 72 | hr | 765 | 2659 | 3152 | 0.8435 | 0.8401 |
Hs 578T | Pelitinib | 10 | uM | LJP5 | 1 | I13 | 72 | hr | 765 | 589 | 3140 | 0.1876 | -0.1205 |
Hs 578T | Pelitinib | 10 | uM | LJP5 | 2 | I13 | 72 | hr | 765 | 634 | 3151 | 0.2012 | -0.0879 |